Role of Platelet Activating Factor as a Mediator of Inflammatory Diseases and Preterm Delivery
The American Journal of Pathology · 2024
DOI: 10.1016/j.ajpath.2024.01.018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The American Journal of Pathology, 2024. Verfasst von Hanan H Wahid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Kulliyyah of Medicine, International Islamic University, Pahang, Malaysia. Electronic address: hananwahid@iium.…. Hauptthemen laut MEDLINE: Platelet Activating Factor, Inflammation, Premature Birth. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 158 Literaturangaben. Gefördert von: Malaysia Ministry of Higher Education.
Abstract (Originalsprache)
Nearly 70% of preterm deliveries occur spontaneously, and the clinical pathways involved include preterm labor and preterm premature rupture of membranes. Prediction of preterm delivery is considered crucial due to the significant effects of preterm birth on health and the economy at both the personal and community levels. Although similar inflammatory processes occur in both term and preterm delivery, the premature activation of these processes or exaggerated inflammatory response triggered by infection or sterile factors leads to preterm delivery. Platelet activating factor (PAF) is a phosphoglycerylether lipid mediator of inflammation that is implicated in infections, cancers, and various chronic diseases and disorders including cardiovascular, renal, cerebrovascular, and central nervous system diseases. In gestational tissues, PAF mediates the inflammatory pathways that stimulate the effector mechanisms of labor, including myometrial contraction, cervical dilation, and fetal membrane rupture. Women with preterm labor and preterm premature rupture of membranes have increased levels of PAF in their amniotic fluid. In mice, the intrauterine or intraperitoneal administration of carbamyl PAF activates inflammation in gestational tissues, thereby eliciting preterm delivery. This review summarizes recent research on PAF as an important inflammatory mediator in preterm delivery and in other inflammatory disorders, highlighting its potential value for prediction, intervention, and prevention of these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, Kulliyyah of Medicine, International Islamic University, Pahang, Malaysia. Electronic address: hananwahid@iium.edu.my.
- Department of Basic Medical Sciences, Kulliyyah of Medicine, International Islamic University, Pahang, Malaysia.
- Department of Human Anatomy, Faculty of Medicine and Health Sciences, University of Putra Malaysia, Selangor, Malaysia.
- Department of Pathology, Kulliyyah of Medicine, International Islamic University, Pahang, Malaysia.
- Department of Obstetrics & Gynaecology, Kulliyyah of Medicine, International Islamic University, Pahang, Malaysia.
Förderung
- Malaysia Ministry of Higher Education
Zitieren
APA
Wahid, H. H., Anahar, F. N., Isahak, N. H., Mohd Zoharodzi, J., Mohammad Khoiri, S. N. L., Mohamad Zainal, N. H., Kamarudin, N., Ismail, H., & Mustafa Mahmud, M. I. A. (2024). Role of Platelet Activating Factor as a Mediator of Inflammatory Diseases and Preterm Delivery. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2024.01.018
Vancouver
Wahid HH, Anahar FN, Isahak NH, Mohd Zoharodzi J, Mohammad Khoiri SNL, Mohamad Zainal NH, et al. Role of Platelet Activating Factor as a Mediator of Inflammatory Diseases and Preterm Delivery. The American Journal of Pathology. 2024. doi:10.1016/j.ajpath.2024.01.018
BibTeX
@article{Wahid2024,
author = {Wahid, Hanan H and Anahar, Fatin N and Isahak, Nurul H and Mohd Zoharodzi, Juwairiyah and Mohammad Khoiri, Siti N L and Mohamad Zainal, Nurul H and Kamarudin, Norhidayah and Ismail, Hamizah and Mustafa Mahmud, Mohammed I A},
title = {Role of Platelet Activating Factor as a Mediator of Inflammatory Diseases and Preterm Delivery},
journal = {The American Journal of Pathology},
year = {2024},
doi = {10.1016/j.ajpath.2024.01.018}
}
EUVIMED